Clinical Trials Directory

Trials / Unknown

UnknownNCT02468531

Xenon Against Postoperative Oxygen Impairment

Protection of Xenon Against Postoperative Oxygen Impairment in Adults Undergoing Stanford Type-A Acute Aortic Dissection Surgery

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
160 (estimated)
Sponsor
Beijing Anzhen Hospital · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Acute lung injury (ALI) is the vital complication of Stanford type A aortic dissection. It is confirmed that Xenon has the significant protective effect on important organs and has no suppression on the cardiovascular system. Furthermore, our earlier trial has already clarified that static inflation with 50% Xenon during cardiopulmonary bypass could attenuate ALI for Standford A acute aortic dissection. However the protection effect was restricted for the limited time. Aimed to enhance the protection effect of Xenon, we designed this randomized trial that anesthesia with 50% xenon one hour before and after CPB and pulmonary static Inflation with 50%,75% and 100% Xenon during CPB respectively.

Conditions

Interventions

TypeNameDescription
OTHERoxygen50% oxygen inhalation
DRUGXenon50% Xenon inhalation

Timeline

Start date
2015-01-01
Primary completion
2017-07-01
Completion
2017-12-01
First posted
2015-06-11
Last updated
2016-11-09

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02468531. Inclusion in this directory is not an endorsement.